Coronavirus Covid-19 Information

MK-3475 630

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab versus placebo as adjuvant therapy following surgery and radiation in participants with high-risk locally advanced cutaneous squamous cell
Study Phase: Phase 3
Principal Investigator: Dr Cliona Grant
Further information

Enquire about a Cancer Clinical Trial

If you would like more information on Cancer Clinical Trials you can contact us.

Make an enquiry